The effect of COVID-19 pandemic on admissions for cannabis-induced psychotic disorder
Introduction Cannabis-induced psychotic disorder (CIPD) is defined by the development of psychotic symptoms during or briefly after intoxication with cannabis or withdrawal from cannabis. The social measures and restrictions implemented following the COVID-19 pandemic might have had an impact on ca...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-06-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S092493382202051X/type/journal_article |
_version_ | 1797616901214437376 |
---|---|
author | A. Elias De Sousa A.S. Machado F. Andrade M. Roque Gonçalves M. Vieira-Coelho |
author_facet | A. Elias De Sousa A.S. Machado F. Andrade M. Roque Gonçalves M. Vieira-Coelho |
author_sort | A. Elias De Sousa |
collection | DOAJ |
description |
Introduction
Cannabis-induced psychotic disorder (CIPD) is defined by the development of psychotic symptoms during or briefly after intoxication with cannabis or withdrawal from cannabis. The social measures and restrictions implemented following the COVID-19 pandemic might have had an impact on cannabis availability, as suggested by patients from our clinical practice, reporting a shortage of the substance.
Objectives
To compare sociodemographic, clinical characteristics and admission rates of inpatient treatment for cannabis-induced psychotic disorder in COVID-19 pandemic period and pre-pandemic period.
Methods
Retrospective observational study of inpatient admissions for CIPD in a psychiatry inpatient unit of a tertiary hospital. The statistical analysis was performed using SPSS software, version 27.0.
Results
Our sample included 120 inpatient admissions, corresponding to 80 patients. Compared to 2018 and 2019, in 2020 there was an overall reduction of 21.5% in inpatient admissions (n=618, 549 and 458, respectively). The number of admissions for CIPD in 2018, 2019, 2020 and 2021 up to september were, respectively, 29, 32, 10 and 31 (5.2%, 6.1%, 2.2% and 7.2% of respective annual admissions). We found no statistically significant differences regarding sociodemographic and clinical characteristics in patients admitted for CIPD during 2020.
Conclusions
These results suggest a disproportionate reduction of inpatient admissions due to CIPD in 2020, followed by an expressive increase in the number of admissions in 2021up to september. This might be related to cannabis availability returning to regular levels. However other factors must be considered, such as the delay of treatment due to reduced accessibility to health care.
Disclosure
No significant relationships.
|
first_indexed | 2024-03-11T07:46:53Z |
format | Article |
id | doaj.art-092f20f190cf4718b4322fa015697c8e |
institution | Directory Open Access Journal |
issn | 0924-9338 1778-3585 |
language | English |
last_indexed | 2024-03-11T07:46:53Z |
publishDate | 2022-06-01 |
publisher | Cambridge University Press |
record_format | Article |
series | European Psychiatry |
spelling | doaj.art-092f20f190cf4718b4322fa015697c8e2023-11-17T05:07:19ZengCambridge University PressEuropean Psychiatry0924-93381778-35852022-06-0165S793S79410.1192/j.eurpsy.2022.2051The effect of COVID-19 pandemic on admissions for cannabis-induced psychotic disorderA. Elias De Sousa0A.S. Machado1F. Andrade2M. Roque Gonçalves3M. Vieira-Coelho4Centro Hospitalar Universitário de São João, Serviço De Psiquiatria, Porto, PortugalFMUP, Departamento De Neurociências Clínicas E Saúde Mental, Porto, PortugalCentro Hospitalar Universitário de São João, Serviço De Psiquiatria, Porto, PortugalCentro Hospitalar Universitário de São João, Serviço De Psiquiatria, Porto, PortugalCentro Hospitalar Universitário de São João, Serviço De Psiquiatria, Porto, Portugal Introduction Cannabis-induced psychotic disorder (CIPD) is defined by the development of psychotic symptoms during or briefly after intoxication with cannabis or withdrawal from cannabis. The social measures and restrictions implemented following the COVID-19 pandemic might have had an impact on cannabis availability, as suggested by patients from our clinical practice, reporting a shortage of the substance. Objectives To compare sociodemographic, clinical characteristics and admission rates of inpatient treatment for cannabis-induced psychotic disorder in COVID-19 pandemic period and pre-pandemic period. Methods Retrospective observational study of inpatient admissions for CIPD in a psychiatry inpatient unit of a tertiary hospital. The statistical analysis was performed using SPSS software, version 27.0. Results Our sample included 120 inpatient admissions, corresponding to 80 patients. Compared to 2018 and 2019, in 2020 there was an overall reduction of 21.5% in inpatient admissions (n=618, 549 and 458, respectively). The number of admissions for CIPD in 2018, 2019, 2020 and 2021 up to september were, respectively, 29, 32, 10 and 31 (5.2%, 6.1%, 2.2% and 7.2% of respective annual admissions). We found no statistically significant differences regarding sociodemographic and clinical characteristics in patients admitted for CIPD during 2020. Conclusions These results suggest a disproportionate reduction of inpatient admissions due to CIPD in 2020, followed by an expressive increase in the number of admissions in 2021up to september. This might be related to cannabis availability returning to regular levels. However other factors must be considered, such as the delay of treatment due to reduced accessibility to health care. Disclosure No significant relationships. https://www.cambridge.org/core/product/identifier/S092493382202051X/type/journal_articleCannabis-induced psychosisdrugsCannabispandemic |
spellingShingle | A. Elias De Sousa A.S. Machado F. Andrade M. Roque Gonçalves M. Vieira-Coelho The effect of COVID-19 pandemic on admissions for cannabis-induced psychotic disorder European Psychiatry Cannabis-induced psychosis drugs Cannabis pandemic |
title | The effect of COVID-19 pandemic on admissions for cannabis-induced psychotic disorder |
title_full | The effect of COVID-19 pandemic on admissions for cannabis-induced psychotic disorder |
title_fullStr | The effect of COVID-19 pandemic on admissions for cannabis-induced psychotic disorder |
title_full_unstemmed | The effect of COVID-19 pandemic on admissions for cannabis-induced psychotic disorder |
title_short | The effect of COVID-19 pandemic on admissions for cannabis-induced psychotic disorder |
title_sort | effect of covid 19 pandemic on admissions for cannabis induced psychotic disorder |
topic | Cannabis-induced psychosis drugs Cannabis pandemic |
url | https://www.cambridge.org/core/product/identifier/S092493382202051X/type/journal_article |
work_keys_str_mv | AT aeliasdesousa theeffectofcovid19pandemiconadmissionsforcannabisinducedpsychoticdisorder AT asmachado theeffectofcovid19pandemiconadmissionsforcannabisinducedpsychoticdisorder AT fandrade theeffectofcovid19pandemiconadmissionsforcannabisinducedpsychoticdisorder AT mroquegoncalves theeffectofcovid19pandemiconadmissionsforcannabisinducedpsychoticdisorder AT mvieiracoelho theeffectofcovid19pandemiconadmissionsforcannabisinducedpsychoticdisorder AT aeliasdesousa effectofcovid19pandemiconadmissionsforcannabisinducedpsychoticdisorder AT asmachado effectofcovid19pandemiconadmissionsforcannabisinducedpsychoticdisorder AT fandrade effectofcovid19pandemiconadmissionsforcannabisinducedpsychoticdisorder AT mroquegoncalves effectofcovid19pandemiconadmissionsforcannabisinducedpsychoticdisorder AT mvieiracoelho effectofcovid19pandemiconadmissionsforcannabisinducedpsychoticdisorder |